Ministère de l'Emploi et de la Solidarité sociale
Consolidated Statutes and Regulations Consolidated Statutes Consolidated Regulations Annual Statutes and Regulations Annual Statutes Annual Regulations Additional information Québec Official Publisher What’s new? Information note Policy of the Minister of Justice Laws: Amendments Laws: Provisions not in force Laws: Provisions brought into force Annual Statutes: PDF versions since 1996 Regulations: Amendments Annual Regulations: PDF versions since 1996 Court Decisions

M-9, r. 12.2.1 - Regulation respecting certain professional activities that may be engaged in by a pharmacist

Section 3
Disposition versions

Full text
3. A pharmacist may also prescribe
(1)  antiviral treatment to a patient showing signs and symptoms similar to herpes zoster, except where they are present in the head region;
(2)  treatment against influenza or coronavirus disease to a symptomatic patient who is at risk of developing complications.
The pharmacist must then enter the reasons for initiating medication therapy on a form to be given to the patient. In addition, the pharmacist must refer the patient to a physician or specialized nurse practitioner:
(1)  within 3 days after the initiation of the antiviral treatment against herpes zoster;
(2)  2 days after the initiation of the treatment against influenza or coronavirus disease, if the condition of the patient deteriorates.
O.C. 1400-2020, s. 3; O.C. 623-2022, s. 1.
3. A pharmacist may also prescribe
(1)  antiviral treatment to a patient showing signs and symptoms similar to herpes zoster, except where they are present in the head region;
(2)  antiviral treatment against influenza to a symptomatic patient who is at risk of developing complications.
The pharmacist must then enter the reasons for initiating medication therapy on a form to be given to the patient. In addition, the pharmacist must refer the patient to a physician or specialized nurse practitioner:
(1)  within 3 days after the initiation of the antiviral treatment against herpes zoster;
(2)  2 days after the initiation of the antiviral treatment against influenza, if the condition of the patient deteriorates.
O.C. 1400-2020, s. 3.
In force: 2021-01-25
3. A pharmacist may also prescribe
(1)  antiviral treatment to a patient showing signs and symptoms similar to herpes zoster, except where they are present in the head region;
(2)  antiviral treatment against influenza to a symptomatic patient who is at risk of developing complications.
The pharmacist must then enter the reasons for initiating medication therapy on a form to be given to the patient. In addition, the pharmacist must refer the patient to a physician or specialized nurse practitioner:
(1)  within 3 days after the initiation of the antiviral treatment against herpes zoster;
(2)  2 days after the initiation of the antiviral treatment against influenza, if the condition of the patient deteriorates.
O.C. 1400-2020, s. 3.
© Gouvernement du Québec